Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

Share Price Information for Tissue Regenix Group (TRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.50
Bid: 64.00
Ask: 67.00
Change: 0.00 (0.00%)
Spread: 3.00 (4.688%)
Open: 65.50
High: 65.50
Low: 65.50
Prev. Close: 65.50
TRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Appointment

31 Oct 2005 07:00

Torex Retail PLC31 October 2005 31 October 2005 Torex Retail Plc New Board Appointment Torex Retail plc is pleased to announce the appointment of Michael Meade asFinance Director with effect from 1st November. Michael (aged 45) joins from UBS Investment Bank where he was a senior directorin the investment banking division. He has specialised for many years advisingmid-cap and technology companies in the UK and Europe, including advising TorexPLC up until its sale. Michael is a Chartered Accountant with considerableexperience in the City and will add strength to the Board's strategic thinking. Chris Moore, Chairman of Torex Retail said: "We are delighted to have someone of Michael's calibre and experience join ourBoard. His arrival represents a further strengthening of our senior managementteam and follows the recently announced appointment of Phil Cox. Phil hasalready made a significant impact in his primary Treasury role, as well as in abroader operational management perspective. We have known Michael for manyyears as a trusted adviser and know he will make a valuable contribution to theBoard in its next stage of development. He joins us at a time when we areexperiencing a continuation of the very strong organic growth Torex achieved inthe first six months of 2005 trading. The integration of the recently acquiredbusinesses continues to run ahead of plan, both in time and quantum, and insome areas is already fully completed. Commenting on his appointment Michael Meade said: "Torex Retail is an exciting growth company which I am delighted to be joining.I believe that there exists a great opportunity to continue to build a worldbeating force in retail systems and I look forward to helping the Companyachieve its ambitious goals." Richard Thompson, whilst remaining with the Group, will move into a moreoperationally focussed finance role. The Board wishes to thank Richard for hisconsiderable contribution to the Group through the Group's initial phase ofdevelopment since IPO. Enquiries: Torex Retail 01295 753313 Chris Moore, Executive Chairman Citigate Dewe Rogerson 020 7638 9571Ginny Pulbrook/Seb Hoyle/Lucie Holloway Michael Meade owns 10,000 ordinary shares in Torex Retail PLC. There are nofurther details to be disclosed as per Rule 17 of the AIM rules. About Torex Retail plc Torex Retail is a leading independent provider of cutting edge retail technologysolutions to many of the world's principal retailers. Since the company'sflotation in spring 2004 Torex Retail has achieved rapid growth across all ofits markets and has rigorously pursued its goal of becoming the provider ofchoice. As a result, the company now has a presence in all of the major marketsaround the world and has built a strong platform for future growth in line withits strategy. Torex's Retail's product and solution set spans high street andout-of-town retail as well as the petroleum and convenience sector and with over6,000 customer relationships, including Tesco, Woolworth, Selfridges, Shell andArgos, the company has earned a leading reputation amongst retailers. TorexRetail has more than 2800 staff based in 17 countries. www.torexretail.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th Feb 20132:38 pmRNSHolding(s) in Company
14th Feb 20137:00 amRNSSuccessful safety study of dCELL® Meniscus
11th Feb 20132:57 pmRNSDirectorate Change
9th Jan 20137:15 amRNSHolding(s) in Company
30th Nov 201211:21 amRNSTissue Regenix board changes
26th Nov 20127:00 amRNSSets up US subsidiary
19th Nov 20127:00 amRNSAdds new patent global licence portfolio
4th Oct 20127:00 amRNSInterim data from clinical trial of dCELL® Dermis
4th Oct 20127:00 amRNSHalf Yearly Report
1st Oct 201210:57 amRNSTissue Regenix - senior development appointment
28th Sep 20123:30 pmRNSNotice of Results
7th Sep 20127:00 amRNSdCELL(R) vascular patch is safe and effective
2nd Aug 20122:31 pmRNSTissue Regenix makes appointment to Cardiac team
31st Jul 20123:02 pmRNSDirector/PDMR Shareholding
19th Jun 20122:39 pmRNSHolding(s) in Company
14th Jun 20127:00 amRNSResearch Update
11th Jun 201212:35 pmRNSResult of AGM
25th May 20127:00 amRNSExpands scope of development activities with NHSBT
10th May 20127:00 amRNSFinal Results
19th Apr 20121:49 pmRNSPoster shown at SAWC
16th Apr 20123:18 pmRNSNotice of Results
7th Feb 20124:00 pmRNSIssue of Equity and Total Voting Rights
11th Jan 201211:36 amRNSHolding(s) in Company
6th Jan 20125:05 pmRNSHolding(s) in Company
3rd Jan 20125:45 pmRNSHolding(s) in Company
3rd Jan 20125:43 pmRNSHolding(s) in Company
3rd Jan 20128:49 amRNSHolding(s) in Company
28th Dec 201112:00 pmRNSResult of General Meeting
8th Dec 201112:53 pmRNSIssue of Equity
25th Nov 20112:23 pmRNSUniversity Partner wins Queen's Anniversary Prize
4th Nov 20112:16 pmRNSHolding(s) in Company
14th Oct 20112:33 pmRNSHolding(s) in Company
10th Oct 20117:00 amRNSHalf Yearly Report
26th Jul 201111:04 amRNSIssue of Equity
7th Jul 20113:52 pmRNSIssue of Share Options
5th Jul 20111:30 pmRNSIssue of Equity
22nd Jun 20118:35 amRNSReceives EUR280,000 Grant Funding
13th Jun 20117:00 amRNSDirectorate Appointment
3rd Jun 201110:02 amRNSAGM Statement
11th May 20117:00 amRNSPositive Results in Clinical Evaluation of dCELL
4th May 20117:00 amRNSFinal Results
21st Apr 20117:00 amRNSTissue Regenix enters commercialisation agreement
29th Mar 20117:00 amRNSDirectorate Change
10th Mar 20117:00 amRNSNotice of allowance of patent received
4th Jan 201111:27 amRNSHolding(s) in Company
30th Dec 20109:05 amRNSHolding(s) in Company
23rd Dec 201012:44 pmRNSChange of Adviser
21st Dec 201010:12 amRNSAdviser - Change of Name
16th Dec 20107:00 amRNSResearch Update
10th Dec 20109:20 amRNSChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.